Key result
Chronic heart failure in rats impaired vasorelaxations, with a lower L-NAME-induced decrease in cGMP level in thoracic aorta segments compared to controls.
Why the study?
Are cGMP- and cAMP-mediated vasorelaxations impaired in rats with chronic heart failure?
Are cGMP- and cAMP-mediated vasorelaxations impaired in rats with chronic heart failure?
Both cGMP- and cAMP-mediated vasorelaxations are impaired in chronic heart failure, likely driven by a reduction in endothelial nitric oxide synthesis.
Answers are grounded in this paper and cite their sources.
Impaired vasorelaxation in this rat HF model is hypothesis-generating; leaves open relevance to human endothelial NO pathways and therapy.
To elucidate pathophysiological alterations in vascular relaxation in rats with chronic heart failure (CHF), guanosine 3',5'-cyclic monophosphate (cGMP)- and adenosine 3',5'-cyclic monophosphate (cAMP)-mediated vasorelaxations in pulmonary artery (PA) and thoracic aorta (TA) of rats were examined 12 wk after coronary artery ligation. Acetylcholine (ACh)-induced relaxation was attenuated in endothelium-intact segments of both arteries, whereas sodium nitroprusside-induced relaxation was attenuated only in endothelium-intact TA segments of rats with CHF. Vasorelaxations elicited by isoproterenol and NKH-477, a water-soluble forskolin analogue, were diminished mainly in PA segments of the CHF rat. NG-nitro-L-arginine methyl ester (L-NAME)-induced decrease in cGMP level was less in endothelium-intact TA segments of the rat with CHF (0.20 +/- 0.06 vs. 0.99 +/- 0.26 pmol/mg protein in control), suggesting that basal nitric oxide (NO) production is reduced in CHF. Treatment with L-NAME attenuated the isoproterenol-induced relaxation only in endothelium-intact TA segments in control rats but not in CHF rats. The results suggest that both cGMP- and cAMP-mediated relaxations are impaired in CHF, and a reduction of NO synthesis, presumably in endothelial cells, plays a significant role in pathophysiological alterations in vessels of rats with CHF.
No takes yet. Share an insight, caveat, or question.
Nasa et al. (1996) studied Chronic heart failure. Chronic heart failure (coronary artery ligation) vs. Control rats was evaluated on L-NAME-induced decrease in cGMP level (pmol/mg protein). Chronic heart failure in rats impaired vasorelaxations, with a lower L-NAME-induced decrease in cGMP level in thoracic aorta segments compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: